PLOD1 and Insulin resistance: These include aberrant gonadotropin secretion patterns with a shift of balance toward elevated luteinizing hormone (LH) levels and insulin resistance leading to compensatory hyperinsulinemia, both of which directly and indirectly lead to clinical or subclinical hyperandrogenemia.